ARMISTICE CAPITAL LLC 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 6:35 pm Purchase | 2021-12-31 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 681 9.990% | 381 (+126.96%) | Filing |
| 2021-06-30 06:16 am Unchanged | 2021-06-29 | 13G | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 300 9.990% | 0 (Unchanged) | Filing |
| 2021-06-30 06:10 am Sale | 2021-06-28 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 300 9.990% | -2,191 (-87.96%) | Filing |
| 2021-06-25 4:21 pm Purchase | 2021-06-15 | 13D | ReShape Lifesciences Inc. RSLS | ARMISTICE CAPITAL LLC | 2,491 49.800% | 2,491 (New Position) | Filing |